STOCKHOLDERS' EQUITY (Tables)

9 Months Ended

Nov. 30, 2016

Equity [Abstract]

Schedule of Stock-based Compensation Expense

Stock-based compensation expense is included in the following captions of the unaudited consolidated statements of comprehensive income (loss) (in thousands):

	Three Months Ended				Nine Months Ended
	November 30,				November 30,
	2016		2015		2016		2015
Cost of revenues	$	118	$	51	$	250	$	170
Research and development		274		217		811		579
Selling		536		325		1,234		820
General and administrative		1,136		1,009		3,374		2,642
	$	2,064	$	1,602	$	5,669	$	4,211

Summary of Stock Option Activity

Changes in the Company’s outstanding stock options during the nine months ended November 30, 2016 were as follows (options in thousands):

			Weighted
	Number of		Average
	Options		Exercise
Outstanding at February 29, 2016	860		$	6.96
Granted	228			14.49
Exercised	(86	)		9.74
Forfeited or expired	(7	)		(15.70	)
Outstanding at November 30, 2016	995		$	8.39
Exercisable at November 30, 2016	664		$	4.92

Summary of Restricted Stock Shares (RSU's), and Performance Stock Units (PSU's) Activity

Changes in the Company’s outstanding restricted stock shares, performance stock units (“PSUs”) and restricted stock units (“RSUs”) during the nine months ended November 30, 2016 were as follows (shares, PSUs and RSUs in thousands):

	Number of
	Restricted		Weighted
	Shares,		Average
	PSUs and		Grant Date
	RSUs		Fair Value
Outstanding at February 29, 2016	953		$	16.66
Granted	760			14.63
Vested	(353	)		14.87
Forfeited	(94	)		15.68
Outstanding at November 30, 2016	1,266		$	16.01